Richard A. Kimball, Jr. is the Managing Partner of Samphire Capital. Samphire Capital is transforming the US healthcare system from volume to value. Samphire Capital is contributing to this critical and historic shift from the fee for service environment to value based reimbursement through a series of investments, consulting and board positions.
Previously, Richard was the Chief Strategy and Growth Officer at Accretive Health, a healthcare technology company, where he was responsible for strategy, business development, sales, marketing, product management and population health. In this role, Richard led the development of a transformation strategy to evolve the company’s innovative revenue cycle management business by facilitating deeper patient engagement by hospitals and building the foundation for population health programs. Richard has built a valued network throughout the healthcare business enabling him to execute on high levels. As a trustee of the Brookings Institution, Richard specializes in health care public policy and is a member of the Audit Committee and the Metropolitan Studies Leadership Council. In addition, he was on the board of the Ralph Lauren Center for Cancer Care and Prevention in Harlem, New York (local health care distribution), a single member corporation of Memorial Sloane Kettering.
Prior to Accretive health, Richard specialized in the healthcare industry as an investment banker and venture capitalist for over 20 years, working at such Wall Street firms as Morgan Stanley (Managing Director), Goldman Sachs (Director/Partner) and Millennium Technology Partners. At these firms, he operated as Co-head of Global Healthcare Investment Banking and Co-head of Healthcare, Consumer and Retail Equity Capital Markets.
Rick Kimball is also member of the Young Presidents Organization (YPO). Education was accomplished at Yale where he received a BA in Economics in 1986. In 2014, Richard was awarded to be a Fellow of the prestigious Stanford Distinguished Career Institute.